News

Published on 9 May 2024 on Insider Monkey via Yahoo Finance

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript


Article preview image

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript May 8, 2024

ACADIA Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good day, everyone, and thank you for standing by. Welcome to the ACADIA Pharmaceuticals First Quarter 2024 Financial Results and Operating Overview Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to Al-Kildani, Senior Vice President of Investor Relations and Corporate Communications. Please proceed.

NASDAQ.ACAD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
ACAD Signs License Deal With Saniona for Rights to Neurology Drug

Acadia Pharmaceuticals ACAD announced that it has signed an exclusive worldwide license agreement...

Zacks · via Yahoo Finance 27 Nov 2024

ACADIA Pharmaceuticals Inc (ACAD): Worst-Performing Growth Stock in 2024

We recently compiled a list of the 10 Worst-Performing Growth Stocks in 2024. In this article, we...

Insider Monkey · via Yahoo Finance 31 Oct 2024

Why Is ACADIA Pharmaceuticals Inc (ACAD) One of the Best Debt Free Halal Stocks...

We recently compiled the list of the 7 Best Halal Stocks To Buy Now (Debt Free). In this article,...

Insider Monkey · via Yahoo Finance 18 Jun 2024

It's Probably Less Likely That ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) CEO Will See A Huge Pay...

Key Insights ACADIA Pharmaceuticals' Annual General Meeting to take place on 29th of MayTotal pay...

Simply Wall St. via Yahoo Finance 22 May 2024

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript May 8, 2024 ACADIA Pha...

Insider Monkey via Yahoo Finance 9 May 2024

Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss

Acadia Pharmaceuticals Inc. ACAD reported first-quarter 2024 earnings of 10 cents per share, beat...

Zacks via Yahoo Finance 8 May 2024

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?

The earnings season for the drug/biotech sector is now in its final lap, with two S&P 500 compani...

Zacks via Yahoo Finance 6 May 2024

Insider Sale: CEO Stephen Davis Sells Shares of ACADIA Pharmaceuticals Inc (ACAD)

On May 2, 2024, Stephen Davis, the CEO of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), sold 11,427 s...

GuruFocus.com via Yahoo Finance 4 May 2024

Acadia Pharmaceuticals CEO sells shares worth $193,573 By Investing.com

Stephen Davis, CEO of Acadia Pharmaceuticals Inc. (NASDAQ:ACAD), recently sold 11,427 shares of t...

Investing.com 3 May 2024

ACADIA Pharmaceuticals Inc CEO Stephen Davis Sells 26,574 Shares

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), a biopharmaceutical company focused on the development ...

GuruFocus.com via Yahoo Finance 10 Apr 2024